Indianapolis, IN4 Active Studies

Liver Disease Clinical Trials in Indianapolis, IN

Find 4 actively recruiting liver disease clinical trials in Indianapolis, IN. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
872
Enrolling

Recruiting Liver Disease Studies in Indianapolis

About Liver Disease Clinical Trials in Indianapolis

Chronic liver disease encompasses conditions that damage the liver over time, including cirrhosis, hepatitis, and fatty liver disease. The liver plays a crucial role in digestion, metabolism, and detoxification. Treatment depends on the cause and may include medications, lifestyle changes, or liver transplant.

There are currently 4 liver disease clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 872 participants. Research is being sponsored by GlaxoSmithKline, Indiana University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Disease Clinical Trials in Indianapolis — FAQ

Are there liver disease clinical trials in Indianapolis?

Yes, there are 4 liver disease clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What liver disease treatments are being tested?

The 4 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for liver disease.

Data updated March 2, 2026 from ClinicalTrials.gov